Onureg 200mg & 300mg Film-coated Tablets
*Company:
Bristol-Myers Squibb Pharma EEIGStatus:
No Recent UpdateLegal Category:
Product subject to medical prescription which may not be renewed (A)Active Ingredient(s):
*Additional information is available within the SPC or upon request to the company
Updated on 20 November 2023
File name
ie-SmPC-clean (18June2021).pdf
Reasons for updating
- Change to section 10 - Date of revision of the text
Legal category:Product subject to medical prescription which may not be renewed (A)
Updated on 11 April 2023
File name
ie-PIL-clean (18June2021).pdf
Reasons for updating
- Change to section 6 - manufacturer
- Change to section 6 - date of revision
Updated on 26 October 2022
File name
Onureg EU SmPC_downloaded from Verity 26Oct2022.pdf
Reasons for updating
- New SPC for new product
Legal category:Product subject to medical prescription which may not be renewed (A)
Free text change information supplied by the pharmaceutical company
new SmPC
Updated on 26 October 2022
File name
Onureg EU PIL_downloaded from Verity 26Oct2022.pdf
Reasons for updating
- New PIL for new product
Free text change information supplied by the pharmaceutical company
new PIL
Bristol-Myers Squibb Pharma EEIG
Address:
Plaza 254, Blanchardstown Corporate Park 2, Dublin 15, D15 T867, IrelandMedical Information E-mail:
medical.information@bms.comTelephone:
+353 1 483 3625Medical Information Direct Line:
Freephone 1 800 749 749Stock Availability:
bmscustomer-service.chester@bms.com